Ryder expands Northeast used truck network with new Newark, North Bergen centers
Bitget2026/10/06 10:55Ryder is expanding its used commercial vehicle sales network in northern New Jersey with a relocated Newark site, opening a new North Bergen center. The former Kearny used vehicle center moved to a larger facility at 474 Wilson Avenue in Newark, near the Port of Newark. A new used truck sales location opened at 6214 Tonnelle Avenue in North Bergen, Ryder’s first south of the George Washington Bridge. The investments target higher customer access across the Northeast, closer to major ports, distribution hubs, Interstate 95, airports, key corridors. Both sites support the Ryder Vehicle Assurance Program, including a free 60-day limited warranty through year-end on eligible DOT Verified vehicles. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ryder System Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261006245577) on October 06, 2026, and is solely responsible for the information contained therein.
- Ryder is expanding its used commercial vehicle sales network in northern New Jersey with a relocated Newark site, opening a new North Bergen center.
- The former Kearny used vehicle center moved to a larger facility at 474 Wilson Avenue in Newark, near the Port of Newark.
- A new used truck sales location opened at 6214 Tonnelle Avenue in North Bergen, Ryder’s first south of the George Washington Bridge.
- The investments target higher customer access across the Northeast, closer to major ports, distribution hubs, Interstate 95, airports, key corridors.
- Both sites support the Ryder Vehicle Assurance Program, including a free 60-day limited warranty through year-end on eligible DOT Verified vehicles.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
No scientific evidence but viral on social media: “Bodybuilding miracle drug” peptide products deregulation file sent to the White House for review, Hims&Hers (HIMS.US) surged 6% in one day.
The temporary admission policy for peptides has been submitted to the White House for review, and compounding pharmacies are expected to receive approval to produce BPC-157 and other substances; HIMS closed up 6% on Thursday.
AiCoin丨10.16 Snapshot: PPI Exceeds Expectations, Russia Bans P2P, US Stock ETF Net Outflow
Yen barely gains on a BoJ push for hikes and a Tokyo stock rout
Crypto prices
More
